Position in EXEL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$674,248
+$154,164 QoQ
Shares Held
12,392
+2.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#388
of 751 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Qtron Investments LLC holds $3,911,455 across 6 Biotechnology names. EXEL ranks #3 (17.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
15,431 | $865,216 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
2,804 | $799,055 | |
| 3 | EXEL |
Exelixis, Inc.
This page
|
12,392 | $674,248 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,344 | $667,605 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
1,992 | $480,012 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
5,434 | $425,319 |
All Filings in EXEL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $674,248 | 12,392 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $520,084 | 12,126 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $468,805 | 10,696 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||